Judge Allows Ariad To Appeal Enbrel Case

Law360, New York (October 6, 2008, 12:00 AM EDT) -- A federal magistrate judge has allowed Ariad Pharmaceuticals Inc. to appeal immediately an earlier decision that rival Amgen Inc. did not infringe its patent related to an arthritis drug.

The magistrate judge for the U.S. District Court for the District of Delaware ruled Friday that "considerations of judicial economy and reduction of litigation expenses" warranted a stay of Amgen's remaining claims against Ariad, and an entry of judgment for Amgen so that Ariad can appeal the case to the Federal Circuit.

Ariad is appealing a ruling...
To view the full article, register now.